Abstract
The daily administration of chlorpromazine (CPZ) in doses of 8–40 mg/kg over 113 weeks to four rhesus monkeys produced dyskinesias and alterations in social behavior. General activity and social interactions were reduced by CPZ treatment but social aggression was elevated during initial drug administration. These behaviors returned to normal when treatment was discontinued. Dyskinesias appeared during CPZ treatment, and two striking ones, gravel mouth and hand gesture, persisted for 12 weeks after drug withdrawal.
These results indicate that dyskinesias which share major features of human tardive dyskinesia can be produced in nonhuman primates by long-term CPZ treatment.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Baldessarini RJ, Tarsy D (1978) Tardive dyskinesia. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: A generation of progress. Raven Press, New York, p 993
Bedard P, Delean J, Lafleur J, Larochelle L (1977) Haloperidol-induced dyskinesias in the monkey. Can J Neurol Sci 4(3):197–201
Christensen AV, Nielsen IM (1979) Dopaminergic supersensitivity: Influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia. Psychopharmacology 62:111–116
Clow A, Jenner P, Marsden CD (1978) An experimental model of tardive dyskinesias. Life Sci 23:421–424
Davis KL, Hollister LE, Vento AL, Beilstein BA, Rosekind GR (1979) Dimethylaminoethanol (Deanol): Effect on apomorphine-induced stereotypy and an animal model of tardive dyskinesia. Pschopharmacology 63:143–146
Eibergen RD, Carlson KR (1975) Dyskinesias elicited by methamphetamine: Susceptibility of former methadone-consuming monkeys. Science 190:588–589
Gunne L, Barany S (1976) Haloperidol-induced tardive dyskinesia in monkeys. Psychopharmacology 50:237–240
Kirk RE (1968) Experimental design. Procedures for the behavioral sciences. Brook and Cole, New York
McKinney WT, Young LD, Suomi SJ, Davis JM (1973) Chlorpromazine treatment of disturbed monkeys. Arch Gen Psychiatry 29:490–494
Messiha FS (1974) The relationship of dopamine excretion to chlorpromazine-induced dyskinesia in monkeys. Arch Int Pharmacodyn Ther 209(1):5–9
Mones RJ (1973) Experimental dyskinesias in normal rhesus monkey. Adv Neurol 1:665–669
Moran EC, McKinney WT (1975) Effects of chlorpromazine on the vertical chamber syndrome in rhesus monkeys. Arch Gen Psychiatry 32:1409–1413
Ng LKY, Gelhard RE, Chase TN, MacLean PD (1973) Drug-induced dyskinesia in monkeys: A pharmacologic model employing 6-hydroxy-dopamine. Adv Neurol 1:651–655
Rubovits R, Patel BC, Klawans HL (1973) Effect of prolonged chlorpromazine pretreatment on the threshold for amphetamine stereotypy: A model for tardive dyskinesias. Adv Neurol 1:671–679
Sackett GP (1968) The persistence of abnormal behaviour in monkeys following isolation rearing. In: Porter R (ed). The role of learning in psychotherapy. J. and A. Churchill, London, p 3
Sassin JF (1975) Drug-induced dyskinesia in monkeys. Adv Neurol 10:47–54
Sayers AC, Burki HR, Ruch W, Asper H (1977) Animal models for tardive dyskinesia: Effects of thioridazine. Pharmakopsychiatr 10:291–295
Tye NC, Horsman L, Wright FC, Pullar IA (1979) Differential enhancement of locomotor activity by dopamine agonists following chronic neuroleptic treatment: An animal model of tardive dyskinesia. Eur J Pharmacol 55:103–107
Weiss B, Santelli S (1978) Dyskinesias evoked in monkeys by weekly administration of haloperidol. Science 200:799–801
Weiss B, Santelli S, Lusink G (1977) Movement disorders induced in monkeys by chronic haloperidol treatment. Psychopharmacology 53:289–293
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McKinney, W.T., Moran, E.C., Kraemer, G.W. et al. Long-term chlorpromazine in rhesus monkeys: Production of dyskinesias and changes in social behavior. Psychopharmacology 72, 35–39 (1980). https://doi.org/10.1007/BF00433805
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00433805